These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8191194)

  • 21. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
    [No Abstract]   [Full Text] [Related]  

  • 22. [The therapy of Raynaud's phenomenon].
    Di Giacinto G
    Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of ketanserin, a selective antagonist of the serotonin (5-HT2) receptors, in primary and secondary Raynaud's phenomenon.
    Meloni F; Transi MG; Sciacca V; De Felice C; Bagarone A; Sciacca A
    Angiology; 1987 Jul; 38(7):530-6. PubMed ID: 3619126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic characteristics of laser-Doppler flux in normal individuals and patients with Raynaud's phenomenon before and after treatment with nifedipine under different thermal conditions.
    Popivanov D; Mineva A; Bendayan P; Leger P; Boccalon H; Möller KO
    Technol Health Care; 1999; 7(2-3):193-203. PubMed ID: 10463308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comments on Raynaud syndrome based on laser-Doppler studies].
    Csiki Z; Gál I; Szücs G; András C; Szegedi G
    Orv Hetil; 1999 Oct; 140(41):2285-8. PubMed ID: 10603742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reaction of red blood cell velocity in nailfold capillaries to local cold in patients with vasospastic disease.
    Mahler F; Meier B; Frey R; Bollinger A; Anliker M
    Bibl Anat; 1977; (16 Pt 2):155-8. PubMed ID: 603504
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
    Varela-Aguilar JM; Sánchez-Román J; Talegón Meléndez A; Castillo Palma MJ
    Rev Clin Esp; 1997 Feb; 197(2):77-83. PubMed ID: 9213861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capillary occlusion and secondary angiogenesis in a patient with Raynaud's phenomenon.
    Jung F; Franke RP; Mrowietz C; Wolf S; Kiesewetter H
    J Vasc Res; 1992; 29(2):71-4. PubMed ID: 1373959
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of Raynaud's syndrome with ketanserin. Clinical, biological and hemodynamic aspects].
    Bellucci S; Kedra AW; Naccache-Herman V; Cambau E; Tobelem G; Caen JP
    Presse Med; 1987 Jul 11-18; 16(27):1335. PubMed ID: 2956601
    [No Abstract]   [Full Text] [Related]  

  • 30. Capillary microscopy is a diagnostic aid in patients with acral ischemia.
    Ubbink DT; Janssen HA; Schreurs MM; Jacobs MJ
    Angiology; 1995 Jan; 46(1):59-64. PubMed ID: 7818158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New treatments for Raynaud's syndrome].
    Bellucci S; Kedra W; Ajzenberg N; Tobelem G; Caen J
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):103-7. PubMed ID: 3290833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
    Matucci Cerinic M; Falcini F; Bartolozzi G; Volpi M
    Int J Clin Pharmacol Res; 1985; 5(1):67-9. PubMed ID: 3997315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of instrumental and technical measurement aspects for clinical capillary microscopy].
    Gasser P; Dubler B
    Z Rheumatol; 1996; 55(4):260-6. PubMed ID: 8967187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon.
    Anderson ME; Allen PD; Moore T; Hillier V; Taylor CJ; Herrick AL
    J Rheumatol; 2005 May; 32(5):841-8. PubMed ID: 15868619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional intravenous ketanserin and guanethidine therapy in Raynaud's phenomenon.
    Caputi CA; De Carolis G; Tomasetti C
    Angiology; 1991 Jun; 42(6):473-80. PubMed ID: 2042796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New prospects for the treatment of Raynaud's phenomenon using a serotoninergic S2 receptor antagonist (ketanserin) and stable derivatives of prostacyclin.
    Pola P; Tondi P; Serricchio M; Favuzzi A; Gerardino L
    Angiology; 1993 Feb; 44(2):123-8. PubMed ID: 8434805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New ways of studying the cutaneous microcirculation in clinical medicine (author's transl)].
    Bollinger A; Jäger K
    Arzneimittelforschung; 1981; 31(11a):2015-9. PubMed ID: 7199291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O; Schmidt JF; Ironmann L
    Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract]   [Full Text] [Related]  

  • 40. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon.
    Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V
    Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.